{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:07:37Z","timestamp":1760123257508},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00408-023-00600-2","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T02:15:33Z","timestamp":1675736133000},"page":"5-7","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bronchodilators in bronchiectasis: we urgently need more trials"],"prefix":"10.1007","volume":"201","author":[{"given":"Miguel \u00c1ngel","family":"Mart\u00ednez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"600_CR1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","volume":"392","author":"PA Flume","year":"2018","unstructured":"Flume PA, Chalmers JD, Olivier KN (2018) Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet 392:880\u2013890","journal-title":"Lancet"},{"key":"600_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.arbres.2019.12.021","volume":"57","author":"MA Martinez-Garc\u00eda","year":"2021","unstructured":"Martinez-Garc\u00eda MA, Villa C, Dobarganes Y et al (2021) RIBRON: the spanish online bronchiectasis registry. characterization of the first 1912 patients. Arch Bronconeumol 57:28\u201335","journal-title":"Arch Bronconeumol"},{"key":"600_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40265-021-01646-3","volume":"82","author":"MA Martinez-Garcia","year":"2022","unstructured":"Martinez-Garcia MA, Oscullo G, Garcia-Ortega A et al (2022) Rationale and clinical use of bronchodilators in adults with bronchiectasis. Drugs 82:1\u201313","journal-title":"Drugs"},{"issue":"3","key":"600_CR4","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ et al (2017) European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 50(3):1700629","journal-title":"Eur Respir J"},{"key":"600_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.arbres.2017.07.016","volume":"54","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2018","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, M\u00e1iz L, Olveira C et al (2018) Spanish guidelines on treatment of bronchiectasis in adults. Arch Bronconeumol 54:88\u201398","journal-title":"Arch Bronconeumol"},{"issue":"Suppl 1","key":"600_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD et al (2019) British Thoracic Society guideline for bronchiectasis in adults. Thorax 74(Suppl 1):1\u201369","journal-title":"Thorax"},{"key":"600_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.arbres.2021.09.001","volume":"58","author":"V Alcaraz-Serrano","year":"2022","unstructured":"Alcaraz-Serrano V, Lee AL, Gimeno-Santos E (2022) Respiratory physiotherapy and bronchiectasis. Arch Bronconeumol 58:377\u2013378","journal-title":"Arch Bronconeumol"},{"key":"600_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00408-022-00540-3","volume":"200","author":"AS Araujo","year":"2022","unstructured":"Araujo AS, Figuereido MR, Lomonaco I et al (2022) Effects of pulmonary rehabilitation on systemic inflammation and exercise capacity in bronchiectasis: a randomized controlled trial. Lung 200:409\u2013417","journal-title":"Lung"},{"key":"600_CR9","first-page":"1453","volume":"82","author":"MA Martinez-Garcia","year":"2022","unstructured":"Martinez-Garcia MA, Oscullo G, Garcia-Ortega A et al (2022) Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: from bench to bedside. A Narrative Rev Drugs 82:1453\u20131468","journal-title":"A Narrative Rev Drugs"},{"key":"600_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1164\/ajrccm.154.2.8756815","volume":"154","author":"PJ Wills","year":"1996","unstructured":"Wills PJ, Wodehouse T, Corkery K et al (1996) Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Am J Respir Crit Care Med 154:413\u20137","journal-title":"Am J Respir Crit Care Med"},{"key":"600_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","volume":"2","author":"AF Barker","year":"2014","unstructured":"Barker AF, O\u00b4Donnell AE, Flume P et al (2014) Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials. Lancet Respir Med 2:738\u201349","journal-title":"Lancet Respir Med"},{"key":"600_CR12","doi-asserted-by":"publisher","first-page":"2102184","DOI":"10.1183\/13993003.02184-2021","volume":"59","author":"L Jayaram","year":"2022","unstructured":"Jayaram L, Vandal AC, Chang CL et al (2022) Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial. Eur Respir J 59:2102184","journal-title":"Eur Respir J"},{"key":"600_CR13","doi-asserted-by":"publisher","unstructured":"Shi ZL, Zhang HY, Peng HB et al (2023) Tiotropium in patients with bronchiectasis: a prospective cohort study. Lung. https:\/\/doi.org\/10.1007\/s00408-023-00597-8","DOI":"10.1007\/s00408-023-00597-8"},{"issue":"58","key":"600_CR14","first-page":"35","volume":"2022","author":"HK Reddel","year":"2021","unstructured":"Reddel HK, Bacharier LB, Bateman ED, Initiative G, for Asthma Strategy, et al (2021) Executive summary and rationale for key changes. Arch Bronconeumol 2022(58):35\u201351","journal-title":"Arch Bronconeumol"},{"key":"600_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, Criner GJ, Martinez FJ et al (2017) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 195:557\u2013582","journal-title":"Am J Respir Crit Care Med"},{"key":"600_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.arbres.2021.08.001","volume":"57","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2021","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1 (2021) Bronchiectasis and eosinophils. Arch Bronconeumol 57:671\u2013672","journal-title":"Arch Bronconeumol"},{"key":"600_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","volume":"205","author":"A Shoemark","year":"2022","unstructured":"Shoemark A, Shteinberg M, De Soyza A et al (2022) Characterization of eosinophilic bronchiectasis: a European Multicohort Study. Am J Respir Crit Care Med 205:894\u2013902","journal-title":"Am J Respir Crit Care Med"},{"key":"600_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.arbres.2022.01.003","volume":"58","author":"F Garc\u00eda-R\u00edo","year":"2022","unstructured":"Garc\u00eda-R\u00edo F, Alc\u00e1zar-Navarrete B, Castillo D et al (2022) Biological biomarkers in respiratory diseases. Arch Bronconeumol 58:323\u2013333","journal-title":"Arch Bronconeumol"},{"key":"600_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.rmed.2018.10.031","volume":"145","author":"D Radovanoic","year":"2018","unstructured":"Radovanoic D, Santus P, Blasi F et al (2018) A comprehensive approach to lug function in bronchiectasis. Resp Med 145:120\u2013129","journal-title":"Resp Med"},{"issue":"7","key":"600_CR20","first-page":"00399","volume":"22","author":"L Traversi","year":"2021","unstructured":"Traversi L, Miravitlles M, Martinez-Garcia MA et al (2021) ROSE: radiology, obstruction, symptoms and exposure - a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group. ERJ Open Res 22(7):00399\u201302021","journal-title":"ERJ Open Res"},{"key":"600_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12931-018-0746-7","volume":"19","author":"A Padilla","year":"2018","unstructured":"Padilla A, Olveira C, Fernandez de Rota L et al (2018) Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients. Respir Res 19:43","journal-title":"Respir Res"},{"key":"600_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.arbres.2019.12.017","volume":"57","author":"T Posadas","year":"2021","unstructured":"Posadas T, Oscullo G, Zaldivar E et al (2021) C-reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. Data from the Spanish Registry of Bronchiectasis (RIBRON). Arch Bronconeumol 57:21\u20137","journal-title":"Arch Bronconeumol"},{"key":"600_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.arbres.2022.04.008","volume":"58","author":"G Scioscia","year":"2022","unstructured":"Scioscia G, Alcaraz-Serrano V, M\u00e9ndez R et al (2022) Factors associated with one-year mortality in hospitalised patients with exacerbated bronchiectasis. Arch Bronconeumol 58:773\u2013775","journal-title":"Arch Bronconeumol"},{"key":"600_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1055\/s-0041-1730944","volume":"42","author":"S Perl","year":"2021","unstructured":"Perl S, Shteinberg M (2021) Bronchiectasis exacerbations: definitions, causes, and acute management. Semin Respir Crit Care Med 42:595\u2013605","journal-title":"Semin Respir Crit Care Med"},{"key":"600_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.arbres.2021.11.003","volume":"58","author":"MB Long","year":"2022","unstructured":"Long MB, Chalmers JD (2022) Treating neutrophilic inflammation in airways diseases. Arch Bronconeumol 58:463\u2013465","journal-title":"Arch Bronconeumol"},{"key":"600_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.arbres.2021.12.001","volume":"58","author":"R Kunadharaju","year":"2022","unstructured":"Kunadharaju R, Rudraraju A, Sethi S (2022) Pseudomonas aeruginosa colonization and COPD: the chicken or the egg? Arch Bronconeumol 58:539\u2013541","journal-title":"Arch Bronconeumol"},{"key":"600_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccm.2021.11.002","volume":"43","author":"MM Aog\u00e1in","year":"2022","unstructured":"Aog\u00e1in MM, Chotirmall SH (2022) Microbiology and the microbiome in bronchiectasis. Clin Chest Med 43:23\u201334","journal-title":"Clin Chest Med"},{"key":"600_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.arbres.2021.08.003","volume":"58","author":"MM Aog\u00e1in","year":"2022","unstructured":"Aog\u00e1in MM, Jaggi TK, Chotirmall SH (2022) The airway microbiome: present and future applications. Arch Bronconeumol 58:8\u201310","journal-title":"Arch Bronconeumol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-023-00600-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-023-00600-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-023-00600-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T14:04:39Z","timestamp":1677333879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-023-00600-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1007\/s00408-023-00600-2","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"18 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"See ICJME of each author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}